Association of GSTM1 null allele with prostate cancer risk: evidence from 36 case-control studies.
BACKGROUND: Glutathione S-transferase M1 (GSTM1) is thought to be involved in detoxifying several carcinogens and may play a vital role in tumorigenesis. Numerous studies have evaluated the association between GSTM1 null/present polymorphism and risk of prostate cancer (PCa). However, the results re...
Main Authors: | Bingbing Wei, Zhuoqun Xu, You Zhou, Jun Ruan, Huan Cheng, Bo Xi, Ming Zhu, Ke Jin, Deqi Zhou, Qiang Hu, Qiang Wang, Zhirong Wang, Zhiqiang Yan, Feng Xuan, Xing Huang, Jian Zhang, Hongyi Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3468624?pdf=render |
Similar Items
-
GSTP1 Ile105Val polymorphism and prostate cancer risk: evidence from a meta-analysis.
by: Bingbing Wei, et al.
Published: (2013-01-01) -
The effect of hOGG1 Ser326Cys polymorphism on cancer risk: evidence from a meta-analysis.
by: Bingbing Wei, et al.
Published: (2011-01-01) -
GSTM1 null polymorphism and palmar dermatoglypics in oral leukoplakia
by: Lakshanika Yogesh, et al.
Published: (2021-01-01) -
Null genotypes of GSTM1 and GSTT1 contribute to risk of cervical neoplasia: an evidence-based meta-analysis.
by: Lin-Bo Gao, et al.
Published: (2011-01-01) -
Assessment of glutathione S-transferaseM1 (GSTM1) and its polymorphisms GSTM1 null in the response to treatment with chemotherapy in advanced ovarian carcinoma
by: Gilberto Kendi Takeda, et al.
Published: (2011-09-01)